Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

Core Insights - Stereotaxis has received European CE Mark approval for its MAGiC™ ablation catheter, marking a significant milestone in the field of surgical robotics for minimally invasive endovascular intervention [1][3][4] - The MAGiC catheter is designed for cardiac ablation procedures to treat heart arrhythmias, enhancing treatment precision and control while maintaining safety [2][3] - The approval follows extensive development, testing, and clinical research, indicating strong potential for broad adoption among robotic users [3][4] Company Overview - Stereotaxis is a pioneer in surgical robotics, focusing on minimally invasive endovascular interventions and has treated over 150,000 patients globally [5] - The company's mission includes the development of robotic systems and solutions that improve patient care and enhance operational efficiency in interventional laboratories [5] Product Features - The MAGiC catheter features optimized navigation, force, and stability through unique magnet placement and design [7] - It offers improved data and information capabilities with iConnect and eContact modules, providing critical contact and temperature data for physicians [7] - The catheter utilizes efficient low-flow uniform cooling to minimize fluid load on patients while preventing char and coagulation [7]